It has been demonstrated that the NGFR-p53 feedback loop is essential for maintaining the melanoma-initiating stem cell-like phenotype, suggesting NGFR as a potential target for developing a molecule-based therapy against melanoma [8,9]. The gene discussed is TP53; the disease is melanoma.